Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) the "Renal Troponin" in Invasive Cardiology?

NCT01612117 is registered in ClinicalTrials.gov with University of Freiburg as lead sponsor.

NCT NCT01612117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01612117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) the "Renal Troponin" in Invasive Cardiology?
Lead sponsor
University of Freiburg
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
February 29, 2012
Enrollment
244 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure